OBED HERNANDEZ: Open Payments
NPI 1831965268 · CLINTON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$205 in 9 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $401 · 2025 $205
Food & beverage: $205
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 3 | $65 |
| Alnylam Pharmaceuticals Inc. | 2 | $49 |
| Myriad Genetic Laboratories, Inc. | 1 | $29 |
| Alexion Pharmaceuticals, Inc. | 1 | $23 |
| Chiesi USA, Inc. | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
Products named: FABRAZYME, MYRISK, ONPATTRO, AMVUTTRA, ELFABRIO, WAINUA.
Industry payments across MS — which companies pay providers there.
